RxNorm Semantic Concepts Index

What is RxNorm?

RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.

The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "".

Concept ID (RxCUI) Name Term Type Term Type Description
100Blood group antibody WeeksDesignated preferred name (PT)
101Substance with direct thrombin inhibitor mechanism of actionDesignated preferred name (PT)
1026-oxoprostaglandin F1 alphaDesignated preferred name (PT)
1036-mercaptopurineDesignated preferred name (PT)
104Apolipoprotein BDesignated preferred name (PT)
105Anorexiant agentDesignated preferred name (PT)
106TimololDesignated preferred name (PT)
107Product containing methylprednisolone and neomycin (medicinal product)Multiple Ingredients (MIN)Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD.
108TrifluoperazineDesignated preferred name (PT)
109avagard (chlorhexidine gluconate 1 % / ethanol 61 % ) Topical LotionSemantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name
1108-oxyquinolDesignated preferred name (PT)
111Vaginal CreamDose Form (DF)
112Vinca alkaloidDesignated preferred name (PT)
113WaxDesignated preferred name (PT)
114Phenol sulfotransferaseDesignated preferred name (PT)
115AscorbaseSynonym (SY)Synonym of another TTY, given for clarity.
116Aspartate transaminaseDesignated preferred name (PT)
117Alupent Inhalant ProductSemantic Branded Dose Form Group (SBDG)Brand Name + Dose Form Group
118Phenytek Oral ProductSemantic Branded Dose Form Group (SBDG)Brand Name + Dose Form Group
119benzethonium Cl 0.15 % / benzocaine 5 % Topical SpraySemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
120AtenololDesignated preferred name (PT)
121Adenosine triphosphate (ATP) citrate (pro-3S)-lyaseDesignated preferred name (PT)
122Phosphatidylinositol 3-kinaseDesignated preferred name (PT)
123biotin / niacinamide / panthenol / zinc pyrithione Medicated ShampooSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
124Product containing autonomic agentDesignated preferred name (PT)
125ODC - Orotidine-5'-monophosphate decarboxylaseSynonym (SY)Synonym of another TTY, given for clarity.
126Home produced spiritDesignated preferred name (PT)
127BIS-EMADesignated preferred name (PT)
128Abortifacient agentDesignated preferred name (PT)
129proparacaine hydrochloride 5 MG/ML [Minims Proxymetacaine hydrochloride]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
130Siberian elm pollen extract 20000 UNT/mL Injectable SolutionSynonym (SY)Synonym of another TTY, given for clarity.
131Picea abies flower bud extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
132Alpha amino isobutyric acidFull form of descriptor (FN)
133Neomycin palmitateDesignated preferred name (PT)
134Smilax regelii root extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
135Frangula purshiana bark extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
136AbrinDesignated preferred name (PT)
137Lactobacillus acidophilus 10000000000 UNTSemantic Clinical Drug Component (SCDC)Ingredient + Strength
13821-deoxycortisolDesignated preferred name (PT)
139BenzethoniumDesignated preferred name (PT)
140CaspofunginFull form of descriptor (FN)
1413,5 T>2<Full form of descriptor (FN)
142hypromellose 0.5 % / phenylephrine 0.12 % Ophthalmic SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
143undecylenic acid 20 % Topical SpraySemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
144miconazole Vaginal Cream [Lagicam]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
1453-methylfentanylFull form of descriptor (FN)
146Piperazine derivativeDesignated preferred name (PT)
147B endorphinDesignated preferred name (PT)
148Beta-galactosidaseDesignated preferred name (PT)
149AcebutololFull form of descriptor (FN)
150HexosaminidaseDesignated preferred name (PT)
151Beta very low density lipoproteinSynonym (SY)Synonym of another TTY, given for clarity.
152BetaxololFull form of descriptor (FN)
153amiloride hydrochloride 5 MG / furosemide 40 MG Oral Tablet [Frusemek]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
154NicoumaloneDesignated preferred name (PT)
155AcetopromazineFull form of descriptor (FN)
156Parakeet feathers specific IgEFull form of descriptor (FN)
157Biological substanceFull form of descriptor (FN)
1585-iodo-2'-deoxycytidineFull form of descriptor (FN)
159palmitamideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
160camphor 4 % / menthol 10 % / methyl salicylate 30 % Topical SpraySemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
161Paracetamol-containing productIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
162AcetanilidSynonym (SY)Synonym of another TTY, given for clarity.
163Cholesterol in VLDL, betaDesignated preferred name (PT)
164acetateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
165AcetokinaseDesignated preferred name (PT)
166anti-inhibitor coagulant complex Injection [Feiba]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
167AcetazolamideFull form of descriptor (FN)
168Acetic acid glacialDesignated preferred name (PT)
169Sweet chestnutSynonym (SY)Synonym of another TTY, given for clarity.
170Orthoboric acidSynonym (SY)Synonym of another TTY, given for clarity.
171FloricalBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
172glycerin / petrolatum / phenylephrine / shark liver oil Rectal CreamSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
173AcetohexamideFull form of descriptor (FN)
174ciprofloxacin Otic Suspension [Otiprio]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
1751-hydroxymethyltriazolamDesignated preferred name (PT)
176Diacetyl reductaseFull form of descriptor (FN)
177Acetolactate synthaseFull form of descriptor (FN)
178AcetoneFull form of descriptor (FN)
179LoncorBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
180Prunus cerasifera whole extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
181sodium hypochlorite 0.62 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
182Fatty-acid methyltransferaseFull form of descriptor (FN)
183Arogenate dehydrogenaseDesignated preferred name (PT)
184Carbohydrate deficient transferrin, asialo fractionFull form of descriptor (FN)
1852-methylacetoacetyl-CoA thiolaseFull form of descriptor (FN)
1863-ketoacyl-CoA thiolaseDesignated preferred name (PT)
187Acetyl-coenzyme A carboxylaseDesignated preferred name (PT)
188Acetyl-CoA acylaseFull form of descriptor (FN)
189Human leukocyte antigen DRw12Designated preferred name (PT)
1901 biotinyl-CoA synthetaseDesignated preferred name (PT)
191calcium hydroxideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
192Beta-L-arabinosidaseDesignated preferred name (PT)
193acetylcarnitineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
194AcetylcholineDesignated preferred name (PT)
195Choline esterase IDesignated preferred name (PT)
196AnticholinesteraseDesignated preferred name (PT)
197NAC - N-acetyl cysteineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
198nadolol 40 MG / bendroflumethiazide 5 MG Oral TabletFull form of descriptor (FN)
199acetyldigoxinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
200acetyleneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
201Acid esteraseFull form of descriptor (FN)
202CarbimazoleFull form of descriptor (FN)
203MegaceBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
204N-Acetyl-beta-glucosaminidaseFull form of descriptor (FN)
205S protein complementFull form of descriptor (FN)
206N-acetylprocainamideSynonym (SY)Synonym of another TTY, given for clarity.
207Acetylserotonin methyltransferaseFull form of descriptor (FN)
208Corzide 40 MG / 5 MG Oral TabletSemantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name
209PRED MILD 0.12 % Ophthalmic SuspensionTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
210AcetyltransferaseDesignated preferred name (PT)
211TopicyclineBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
212Hb 80(EF4), Asp-asnFull form of descriptor (FN)
213chlordiazepoxide hydrochloride 10 MG Oral Capsule [Libritabs]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
214Acid lipaseDesignated preferred name (PT)
215PurgativeDesignated preferred name (PT)
216Child SilapapBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
21712 HR dextromethorphan HBr 50 MG / guaifenesin 400 MG / K+ guaiacolsulfonate 200 MG Extended Release Oral CapsuleTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
218ceFAZolinDesignated preferred name (PT)
219Acid phosphomonoesteraseFull form of descriptor (FN)
220Special CBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
221ZartanBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
222L-3-aminoisobutyrateFull form of descriptor (FN)
223Cefalexin-containing productIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
224DHAS - Dehydroepiandrosterone sulfateFull form of descriptor (FN)
225Liquifilm TearsBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
226Marcain HeavyBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
227CeruloplasminDesignated preferred name (PT)
228Venombin ADesignated preferred name (PT)
229dichlorobenzyl alcoholIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
230Genetically modified virusFull form of descriptor (FN)
231Dihydrodipicolinate synthaseDesignated preferred name (PT)
232MCFFull form of descriptor (FN)
233Prostaglandin PGF2 alpha tromethamineDesignated preferred name (PT)
234dipipanoneFull form of descriptor (FN)
235Deoxyribonucleic acid beta-glucosyltransferaseDesignated preferred name (PT)
236acidulated phosphate fluorideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
237LevomethadylFull form of descriptor (FN)
238estradiol 0.05 MG/Day Weekly Transdermal SystemSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
239AclarubicinDesignated preferred name (PT)
240Chlorphenamine-containing productDesignated preferred name (PT)
241AconitaseFull form of descriptor (FN)
242aconiteIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
243NH4Cl 200 MG / Guaifenesin 100 MG Oral TabletTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
244Cholesterol desmolaseFull form of descriptor (FN)
245Choline acetylaseSynonym (SY)Synonym of another TTY, given for clarity.
246Mephobarbital 90 MG / DPH 60 MG Oral TabletSynonym (SY)Synonym of another TTY, given for clarity.
247zinc pyrithione 2 MG/ML [Head & Shoulders]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
248chloramphenicol 4 MG/ML Ophthalmic SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
249euflavineFull form of descriptor (FN)
250Fibrinogen Seattle IIFull form of descriptor (FN)
251ketotifen 1 MG / theophylline 200 MG Extended Release Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
252vitamin K3 10 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
253Chymotrypsin A and BSynonym (SY)Synonym of another TTY, given for clarity.
254CilastatinFull form of descriptor (FN)
255AcrosinDesignated preferred name (PT)
256ephedrine hydrochloride 4.7 MG/MLTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
257Gentamicin acetyltransferase 1Full form of descriptor (FN)
258ClenbuterolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
259ClobetasolFull form of descriptor (FN)
260Glycerophosphocholine phosphodiesteraseFull form of descriptor (FN)
261Maalox Quick Dissolve Maximum Strength 1000 MG (Ca 400 MG) Chewable TabletSemantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name
262Actin-binding proteinFull form of descriptor (FN)
263TositumomabIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
264TrichomycinDesignated preferred name (PT)
265Cobra venomFull form of descriptor (FN)
266CoccidioidinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
267Methyl morphineFull form of descriptor (FN)
268Acyl-CoA reductaseFull form of descriptor (FN)
269HDL2 - High density lipoprotein subfraction 2Full form of descriptor (FN)
270SpectinomycinFull form of descriptor (FN)
271ActinDesignated preferred name (PT)
272Charcoal activatedSynonym (SY)Synonym of another TTY, given for clarity.
273hylanIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
274ActomyosinSynonym (SY)Synonym of another TTY, given for clarity.
275Complement component C1Designated preferred name (PT)
276Active C3bFull form of descriptor (FN)
277C6 - complement component 6Full form of descriptor (FN)
278C5b-9 - complement 5b-9 complexSynonym (SY)Synonym of another TTY, given for clarity.
279isoconazoleDesignated preferred name (PT)
280Acute phase reactantFull form of descriptor (FN)
281Aciclovir-containing productDesignated preferred name (PT)
282Ketorolac trometamolSynonym (SY)Synonym of another TTY, given for clarity.
283Acyl coenzyme ADesignated preferred name (PT)
284travoprost 0.004 % Ophthalmic SolutionPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
285CMPsialate pyrophosphorylaseDesignated preferred name (PT)
286LTA-4 hydrolaseSynonym (SY)Synonym of another TTY, given for clarity.
287lidamidineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
28817,21-hydroxyprogesteroneFull form of descriptor (FN)
289Tetracosactide-containing productSynonym (SY)Synonym of another TTY, given for clarity.
2906-aminopurineFull form of descriptor (FN)
291CKBB - Creatine kinase BB isoenzymeDesignated preferred name (PT)
292Maleylacetate reductaseFull form of descriptor (FN)
293TransphosphoribosidaseDesignated preferred name (PT)
294CryoglobulinFull form of descriptor (FN)
295meningococcal group A polysaccharideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
296AdenosineFull form of descriptor (FN)
297CyclandelateDesignated preferred name (PT)
298N-Methylglutamate synthaseDesignated preferred name (PT)
299methylnicotinateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
300CyclopenthiazideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
301MMDASynonym (SY)Synonym of another TTY, given for clarity.
302mofebutazoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
303ADA - Adenosine deaminaseDesignated preferred name (PT)
304ADPDesignated preferred name (PT)
305ProtocollagenDesignated preferred name (PT)
306Cytochrome p-450 enzymeDesignated preferred name (PT)
307etoricoxibFull form of descriptor (FN)
308Adenosine kinaseDesignated preferred name (PT)
309AMPSynonym (SY)Synonym of another TTY, given for clarity.
310Actinomycin DIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
311DDDSynonym (SY)Synonym of another TTY, given for clarity.
312ATPaseFull form of descriptor (FN)
313sodium chloride 0.9 % Nasal SolutionFull form of descriptor (FN)
314Ca^2+^-transporting adenosine triphosphataseDesignated preferred name (PT)
315benzalkonium 0.2 MG/ML / chloroxylenol 1 MG/ML / hydrocortisone 10 MG/ML Otic SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
316glycopyrrolate 1 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
317Na^+^/K^+^-transporting adenosine triphosphataseDesignated preferred name (PT)
318ATP - Adenosine triphosphateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
319DeodorantDesignated preferred name (PT)
320Norleucine aminotransferaseDesignated preferred name (PT)
3213',5'-cyclic AMP synthetaseFull form of descriptor (FN)
322MyokinaseFull form of descriptor (FN)
323AdenylosuccinaseSynonym (SY)Synonym of another TTY, given for clarity.
324IMP-aspartate ligaseSynonym (SY)Synonym of another TTY, given for clarity.
325DesmopressinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
326oxaprozinFull form of descriptor (FN)
327DexolBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
328Palladium chlorideDesignated preferred name (PT)
329DextromoramideFull form of descriptor (FN)
330methacycline 300 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
331DialysateDesignated preferred name (PT)
332Adipex-PBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
333adiphenineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
334mebendazole 40 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
335Clodronic acidIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
336ImmunostimulantDesignated preferred name (PT)
337trimipramine 75 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
338rRNA N-glycosidaseFull form of descriptor (FN)
339StilbestrolSynonym (SY)Synonym of another TTY, given for clarity.
340Digitalis glycosideDesignated preferred name (PT)
341anidulafunginDesignated preferred name (PT)
342Polyphosphate kinaseDesignated preferred name (PT)
343dihydroxyacetoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
344prenylamine lactateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
345GQ1b ganglioside antibodyDesignated preferred name (PT)
346leuprolide 22.5 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
347nitrogen 99.5 % Gas for InhalationSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
348oxygen 99.1 % Gas for InhalationPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
349lamoTRIgine 2 MG Chewable Dispersible TabletDesignated preferred name (PT)
350DiphenoxylateDesignated preferred name (PT)
351Diphtheria immunoglobulinDesignated preferred name (PT)
352DiprenorphineDesignated preferred name (PT)
353Tannic-12 SBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
354Adrenal cortical hormone-containing productDesignated preferred name (PT)
355RibokinaseFull form of descriptor (FN)
356Phosphoribulose epimeraseDesignated preferred name (PT)
357Thiazide diureticDesignated preferred name (PT)
358roxatidine acetatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
359Accuzyme 830,000 UNT/GM / 10 % Topical OintmentPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
360S-Alkylcysteine lyaseDesignated preferred name (PT)
361salicinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
362Adrenaline hydrochlorideSynonym (SY)Synonym of another TTY, given for clarity.
363tinzaparin Injectable Solution [Innohep]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
364DoxycyclineFull form of descriptor (FN)
365SialooligosaccharideFull form of descriptor (FN)
366Substance with alpha adrenergic receptor agonist mechanism of actionDesignated preferred name (PT)
367Substance with alpha adrenergic receptor antagonist mechanism of actionDesignated preferred name (PT)
368Beta-1 adrenergic receptorDesignated preferred name (PT)
369Beta-2 adrenergic receptorDesignated preferred name (PT)
370Substance with beta adrenergic receptor agonist mechanism of actionDesignated preferred name (PT)
371Beta blockerFull form of descriptor (FN)
372edrophonium Injectable SolutionSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
373Sucrose glucosyltransferaseFull form of descriptor (FN)
374Substance with adrenergic receptor agonist mechanism of actionFull form of descriptor (FN)
375AdrenochromeFull form of descriptor (FN)
376CorticotrophinSynonym (SY)Synonym of another TTY, given for clarity.
377calcium iodized / peptone,dried / thyroid (USP) Oral TabletSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
378Elapid venomFull form of descriptor (FN)
379ascorbic acid / ferrous gluconate / vitamin B12 Oral TabletSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
380Sporothrix species antibodyFull form of descriptor (FN)
381torsemide Oral Tablet [Torem]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
382EmetineDesignated preferred name (PT)
383TioxidazoleFull form of descriptor (FN)
384AtomoxetineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
385fluocinonide Topical SolutionSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
386fosfestrol Oral Tablet [Honvan]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
387hypromellose 0.32 % Ophthalmic SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
388Polymyxin B sulfateFull form of descriptor (FN)
389Mite specific IgGFull form of descriptor (FN)
390IV fluidSynonym (SY)Synonym of another TTY, given for clarity.
391Ubiquitin--protein ligaseFull form of descriptor (FN)
392EnfluraneDesignated preferred name (PT)
393Ribonucleic acid uridylyltransferaseFull form of descriptor (FN)
394AFT - AflatoxinFull form of descriptor (FN)
395VLDL - Very low density lipoprotein triglycerideFull form of descriptor (FN)
396Substance with enzyme mechanism of actionDesignated preferred name (PT)
397agarDesignated preferred name (PT)
398XamoterolFull form of descriptor (FN)
399EpimeraseFull form of descriptor (FN)
400AgglutininFull form of descriptor (FN)
401GP120 V-FMS proteinDesignated preferred name (PT)
402ZOLMitriptan 5 MG/ACTUAT Nasal SprayDesignated preferred name (PT)
403sulfamethoxazole / trimethoprim Injectable Solution [Bactrim]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
404Eritrityl tetranitrateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
405DispermoxBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
406ErythroseFull form of descriptor (FN)
407Azinphos-ethylFull form of descriptor (FN)
408Cricetinae proteinSynonym (SY)Synonym of another TTY, given for clarity.
409Estramustine sodium phosphateDesignated preferred name (PT)
410EstrogenSynonym (SY)Synonym of another TTY, given for clarity.
411medical airSynonym (SY)Synonym of another TTY, given for clarity.
412diethylpropion 60 MG Extended Release Oral CapsuleSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
413Inosine monophosphate cyclohydrolaseFull form of descriptor (FN)
414Ethyl biscoumacetateFull form of descriptor (FN)
415Monobasic Pot phosphate 6 MMOL/ML Injectable SolutionSynonym (SY)Synonym of another TTY, given for clarity.
416ISOtretinoin 0.00025 MG/MG Topical GelTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
417Etynodiol diacetateDesignated preferred name (PT)
418EtorphineFull form of descriptor (FN)
419lidocaine 50 MG/MG / triamcinolone 0.25 MG/MG Topical OintmentSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
420cefatrizine 100 MG/ML Oral SuspensionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
421cetrimide 15 MG/ML Topical SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
422glycerin 634 MG/ML Oral SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
423ajmalineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
424resorcinol 20 MG/ML / salicylic acid 20 MG/ML / sodium thiosulfate 88 MG/ML Topical LotionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
425Activated Christmas FactorSynonym (SY)Synonym of another TTY, given for clarity.
426Alpha-aminopropionic acidDesignated preferred name (PT)
427ALT - alanine aminotransferaseFull form of descriptor (FN)
428Alanine racemaseDesignated preferred name (PT)
429Alanyl-tRNA synthetaseSynonym (SY)Synonym of another TTY, given for clarity.
430AlbendazoleIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
431buclizine 12.5 MG / Hydroxyzine 10 MG / vit-B3 25 MG Oral TabletTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
432progabide 300 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
433AlbuminFull form of descriptor (FN)
434sulfathiazole 500 MG Oral TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
435Salbutamol-containing productFull form of descriptor (FN)
436lecithin 600 MG Oral CapsulePrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
437alibendol 100 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
438bromelains 45 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
439ADH - Alcohol dehydrogenaseDesignated preferred name (PT)
440HLA AbSynonym (SY)Synonym of another TTY, given for clarity.
441ketanserin Topical GelSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
442Fish venomFull form of descriptor (FN)
443hydroxypropylcellulose 5 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
444FlavoxateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
445FluconazoleIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
446FlunitrazepamDesignated preferred name (PT)
447oxilofrine 32 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
448Ethyl alcoholSynonym (SY)Synonym of another TTY, given for clarity.
449FluorometholoneDesignated preferred name (PT)
450Fludroxycortide-containing productSynonym (SY)Synonym of another TTY, given for clarity.
451propafenone 10 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
452theophylline 40 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
453FormaldehydeFull form of descriptor (FN)
454FIGLUSynonym (SY)Synonym of another TTY, given for clarity.
455AlcoholFull form of descriptor (FN)
456FFP - Fresh frozen plasmaSynonym (SY)Synonym of another TTY, given for clarity.
457Fruit sugarSynonym (SY)Synonym of another TTY, given for clarity.
458Human follicle stimulating hormoneFull form of descriptor (FN)
459FumaraseFull form of descriptor (FN)
460AlcuroniumIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
461Aldehyde dehydrogenase (nicotinamide adenine dinucleotide ^+^)Designated preferred name (PT)
462GAG-ONC proteinFull form of descriptor (FN)
463Galactose-1-phosphate uridyl transferaseFull form of descriptor (FN)
464Annexin IVDesignated preferred name (PT)
465Aldehyde-lyaseFull form of descriptor (FN)
466AldehydeDesignated preferred name (PT)
467Recombinant human soluble insulinDesignated preferred name (PT)
468BasaljelBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
469BradophenSynonym (SY)Synonym of another TTY, given for clarity.
470Substance with protein kinase inhibitor mechanism of actionDesignated preferred name (PT)
471Aldose reductaseFull form of descriptor (FN)
472Blasticidin-S deaminaseDesignated preferred name (PT)
473brain-derived neurotrophic factorIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
474General anesthetic agentsDesignated preferred name (PT)
475Substance with aldosterone receptor antagonist mechanism of actionDesignated preferred name (PT)
476E. coli exonuclease ISynonym (SY)Synonym of another TTY, given for clarity.
477diphenhydramine citrate 19 MGTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
478Oxytetracycline hydrochloridePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
479AlfentaBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
480AlfentanilDesignated preferred name (PT)
481ThornDesignated preferred name (PT)
482ClavulanateSynonym (SY)Synonym of another TTY, given for clarity.
483acetaminophen 10 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
484Walnut tree dustDesignated preferred name (PT)
485D-glucoseSynonym (SY)Synonym of another TTY, given for clarity.
486chlorothen 0.6 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
487GlucosidaseDesignated preferred name (PT)
488Glutamate decarboxylaseFull form of descriptor (FN)
489L-glutathioneFull form of descriptor (FN)
490Glutathione S-alkyltransferaseFull form of descriptor (FN)
491GlycerolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
492HydrostatBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
493PegintronBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
494Alkaline phosphomonoesteraseFull form of descriptor (FN)
495ThiocylBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
496AlkaloidFull form of descriptor (FN)
497PrialtBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
498AurothioglucoseFull form of descriptor (FN)
499Cottonseed meal toxinSynonym (SY)Synonym of another TTY, given for clarity.
500FerrlecitBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
501GramicidinFull form of descriptor (FN)
502FrigidermBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
503GuaiacolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
504Alkylating agentFull form of descriptor (FN)
505DinitroglycerolSynonym (SY)Synonym of another TTY, given for clarity.
506GoserelinDesignated preferred name (PT)
507halofantrineDesignated preferred name (PT)
5085-ureidohydantoinDesignated preferred name (PT)
509HaloperidolFull form of descriptor (FN)
510HarmidineDesignated preferred name (PT)
511Human chorionic gonadotrophin, alpha subunitSynonym (SY)Synonym of another TTY, given for clarity.
512Hyocholic acidDesignated preferred name (PT)
513AllethrinSynonym (SY)Synonym of another TTY, given for clarity.
514He - HeliumIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
515HaematinDesignated preferred name (PT)
516allobarbitalFull form of descriptor (FN)
517Threo 2-amino 3-methylpentanoic acidDesignated preferred name (PT)
518Allophanate hydrolaseDesignated preferred name (PT)
519AllopurinolFull form of descriptor (FN)
520Allosteric siteFull form of descriptor (FN)
521HemopexinDesignated preferred name (PT)
522Hemostatic agentDesignated preferred name (PT)
523Hepatitis antibodyFull form of descriptor (FN)
524manganese gluconateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
525AllylestrenolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
526Methionine aminopeptidaseDesignated preferred name (PT)
527Metubine IodideBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
528AlmitrineFull form of descriptor (FN)
529almitrine dimesylatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
530HexestrolDesignated preferred name (PT)
531Beta-N-acetylhexosaminidase BDesignated preferred name (PT)
532HexylresorcinolFull form of descriptor (FN)
533Diamine oxidaseSynonym (SY)Synonym of another TTY, given for clarity.
534A-1ACT - alpha-1-antichymotrypsinFull form of descriptor (FN)
535AAT - alpha-1-antitrypsinSynonym (SY)Synonym of another TTY, given for clarity.
536Histone kinaseFull form of descriptor (FN)
537Endothelium-derived relaxation factor-forming enzymeFull form of descriptor (FN)
538Human leukocyte antigen ADesignated preferred name (PT)
539HLA - Human leukocyte antigen B8Synonym (SY)Synonym of another TTY, given for clarity.
540A-2M - alpha-2 macroglobulinFull form of descriptor (FN)
541Interferon alfaFull form of descriptor (FN)
542guaifenesin 600 MG / phenylephrine hydrochloride 18 MG Extended Release Oral TabletTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
543Miltuss EXBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
544Alpha-fetoglobulinFull form of descriptor (FN)
545Alpha globulinFull form of descriptor (FN)
546brompheniramine / hydrocodone / pseudoephedrine Oral Solution [Bromplex HD]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
547HydralazineFull form of descriptor (FN)
548Chlorinated hydrocarbonDesignated preferred name (PT)
549PolicresulenFull form of descriptor (FN)
550dibasic potassium phosphateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
551Prohormone converting enzymeDesignated preferred name (PT)
552HydroxychloroquineDesignated preferred name (PT)
553hydroxyestronesIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
554Hydroxymethylglutaryl-coenzyme A synthaseDesignated preferred name (PT)
555Hydroxycarbamide-containing productIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
556Rhizopus aspartic proteinaseSynonym (SY)Synonym of another TTY, given for clarity.
559Hypnotic agentDesignated preferred name (PT)
560alpha-amylaseFull form of descriptor (FN)
561sennoside BDesignated preferred name (PT)
562cephalexin Chewable TabletSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
563pirbuterol 1.5 MG/ML [Exirel]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
564p-Isobutylhydratropic acidDesignated preferred name (PT)
565IdarubicinFull form of descriptor (FN)
566Immunoglobulin A1Full form of descriptor (FN)
567IgG2 - Immunoglobulin G2Synonym (SY)Synonym of another TTY, given for clarity.
568ofloxacin 300 MG [Floxin]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
569EflornithineFull form of descriptor (FN)
570acetaminophen 325 MG [Uni-Ace]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
571Immunoglobulin fragmentDesignated preferred name (PT)
572Igs - ImmunoglobulinsDesignated preferred name (PT)
573Lambda light chainSynonym (SY)Synonym of another TTY, given for clarity.
574estradiol 0.0006 MG/MG [Oestrogel]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
575MaltaseSynonym (SY)Synonym of another TTY, given for clarity.
576ezetimibe 10 MG [Zetia]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
577estradiol 0.45 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
578bromfenac 0.9 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
579Minor lactalbuminDesignated preferred name (PT)
580petrolatum 0.568 MG/MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
581lactase 15 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
582isopropyl alcohol 0.95 ML/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
583Alpha-MSHFull form of descriptor (FN)
584Infant formulaDesignated preferred name (PT)
585Insulin solubleFull form of descriptor (FN)
586Active C14b2aDesignated preferred name (PT)
587Insulin proteaseFull form of descriptor (FN)
588Interferon alfa-2bFull form of descriptor (FN)
589B-cell growth factorIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
590EtazocineDesignated preferred name (PT)
591Gamma foetoproteinDesignated preferred name (PT)
592IF - Intrinsic factorDesignated preferred name (PT)
593chromium picolinateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
594AlphaprodineDesignated preferred name (PT)
595algestoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
596AlprazolamTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
597AlprenololFull form of descriptor (FN)
598Prostaglandin PGE1Designated preferred name (PT)
599AlseroxylonFull form of descriptor (FN)
600Human leucocyte antigen Bw75Synonym (SY)Synonym of another TTY, given for clarity.
601IsocarboxazidIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
602dorzolamideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
603sodium phosphate 1500 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
604Hb 22(B4), Glu-glnFull form of descriptor (FN)
605Donatussin MAXBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
606Moisture Eyes PMBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
607pregabalin 100 MG [Lyrica]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
608meperidine Oral SolutionSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
609tocamphylIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
610Lymphocyte antigen CD66BDesignated preferred name (PT)
611Aluminum aspirinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
612AlgeldrateDesignated preferred name (PT)
613Aluminium hydroxide gelFull form of descriptor (FN)
614ExjadeBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
615Aluminium oxideDesignated preferred name (PT)
616OrenciaBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
617Type IV collagenaseSynonym (SY)Synonym of another TTY, given for clarity.
618KynureninFull form of descriptor (FN)
619AmanitotoxinSynonym (SY)Synonym of another TTY, given for clarity.
620AmantadineFull form of descriptor (FN)
621Amantadine sulfateFull form of descriptor (FN)
622Product containing benzalkonium and cetrimide (medicinal product)Designated preferred name (PT)
623AmbenoniumIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
624Ambestigmine chlorideDesignated preferred name (PT)
625AmbroxolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
626Mecillinam-containing productDesignated preferred name (PT)
627Pivmecillinam-containing productSynonym (SY)Synonym of another TTY, given for clarity.
628Absorbable gelatin spongeDesignated preferred name (PT)
629By AcheBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
630hydrofluoric acid 5 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
631citric acid 32.4 MG/ML / magnesium oxide 3.8 MG/ML / sodium carbonate 4.3 MG/ML [Urologic G]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
632Mitomycin-CFull form of descriptor (FN)
633Hemofiltration solutionBritish preferred term (PTGB)
635TransamidinaseSynonym (SY)Synonym of another TTY, given for clarity.
636Keratol HCBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
637LevallorphanDesignated preferred name (PT)
638Phosphoribosyldiphosphate 5-amidotransferaseDesignated preferred name (PT)
639Amidotrizoic acidDesignated preferred name (PT)
640linoleic acidPrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
641AmikacinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
642LipopolysaccharideFull form of descriptor (FN)
643Amikacin sulfateBritish synonym (SYGB)British synonym of another TTY, given for clarity.
644AmilorideDesignated preferred name (PT)
645Aminoacridine-containing productSynonym (SY)Synonym of another TTY, given for clarity.
646fluconazole 200 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
647LorazepamFull form of descriptor (FN)
648ferrous fumarate 322 MG / folic acid 350 MCG Oral TabletDesignated preferred name (PT)
651LymecyclineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
652LymphokineFull form of descriptor (FN)
653LypressinDesignated preferred name (PT)
654Ethopropazine hydrochlorideSynonym (SY)Synonym of another TTY, given for clarity.
655acetaminophen / caffeine / salicylamide Oral CapsuleSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
656Amino-acid racemaseDesignated preferred name (PT)
657MafenideFull form of descriptor (FN)
658Magnesium hydrateSynonym (SY)Synonym of another TTY, given for clarity.
659Branched-chain amino acidDesignated preferred name (PT)
660Malic dehydrogenaseSynonym (SY)Synonym of another TTY, given for clarity.
661CervarixBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
662Dicarboxylic amino acidDesignated preferred name (PT)
663Essential amino acidDesignated preferred name (PT)
664KemstroBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
665Sulfur-bearing amino acidFull form of descriptor (FN)
666MaxataseFull form of descriptor (FN)
667diethylpropion Extended Release Oral Tablet [Tepanil]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
668MedazepamDesignated preferred name (PT)
669MedrogestoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
670linezolid 400 MG Oral Tablet [Zyvox]Synonym (SY)Synonym of another TTY, given for clarity.
671MelarsoprolFull form of descriptor (FN)
672chlorpheniramine / hydrocodone / phenylephrine Oral Solution [NUDAL HD]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
673Beta-alanine-oxoglutarate aminotransferaseFull form of descriptor (FN)
674PhosphoadenylylsulfataseFull form of descriptor (FN)
675MentholFull form of descriptor (FN)
676MeprobamateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
677AminoglutethimideDesignated preferred name (PT)
678AminoglycosideDesignated preferred name (PT)
679Antigen Ki67Designated preferred name (PT)
6804-hydroxybenzoate-CoA synthetaseDesignated preferred name (PT)
681piroxicam-beta-cyclodextrinFull form of descriptor (FN)
682AIB - Aminoisobutyric acidDesignated preferred name (PT)
683ALA - delta-aminolevulinic acidFull form of descriptor (FN)
684Aminolevulinate dehydrataseFull form of descriptor (FN)
685Aminolevulinate synthaseSynonym (SY)Synonym of another TTY, given for clarity.
686MethyclothiazideFull form of descriptor (FN)
687Peptidase aDesignated preferred name (PT)
688salicylic acid 0.03 MG/MG [Keralyt]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
689AminophyllineFull form of descriptor (FN)
690AQP-2Designated preferred name (PT)
691Beta-aminopropionitrileSynonym (SY)Synonym of another TTY, given for clarity.
692MetrizamideDesignated preferred name (PT)
693ethynodiol / mestranolMultiple Ingredients (MIN)Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD.
694benzocaine 63 MG/ML [Anbesol]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
695AminophenazoneIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
696MidazolamIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
697LeucenineDesignated preferred name (PT)
698MinocyclineDesignated preferred name (PT)
699MisonidazoleDesignated preferred name (PT)
700cider vinegar 300 MG Oral TabletPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
701Lactobacillus bifidus 25 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
702menthol / methyl salicylate / methylnicotinate Topical CreamSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
703AmiodaroneDesignated preferred name (PT)
704AmitriptylineDesignated preferred name (PT)
705cefixime 40 MG/ML [Suprax]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
706Glucose dehydrogenaseFull form of descriptor (FN)
707Non-human hair - materialFull form of descriptor (FN)
708Ammonia-lyaseFull form of descriptor (FN)
709ammoniumIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
710Product containing codeine and guaiacol (medicinal product)Designated preferred name (PT)
711VyvanseBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
712Ammonium chlorideFull form of descriptor (FN)
713Erythropoetin deltaFull form of descriptor (FN)
714Product containing cefuroxime and metronidazole (medicinal product)Designated preferred name (PT)
715PrimperanBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
716Contact lens preparationsDesignated preferred name (PT)
717Sunless tanning lotionFull form of descriptor (FN)
718Myosin adenosine triphosphataseSynonym (SY)Synonym of another TTY, given for clarity.
719AmylobarbitoneSynonym (SY)Synonym of another TTY, given for clarity.
720AmodiaquineDesignated preferred name (PT)
721Arylamine sulfotransferaseFull form of descriptor (FN)
722AmoxapineFull form of descriptor (FN)
723AmoxicillinDesignated preferred name (PT)
724AMP aminaseSynonym (SY)Synonym of another TTY, given for clarity.
725Amfetamine-containing productSynonym (SY)Synonym of another TTY, given for clarity.
726guaiacolsulfonate / HYDROcodone Oral Solution [Atuss EX]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
727Natriuretic hormoneSynonym (SY)Synonym of another TTY, given for clarity.
728Amphibian venomDesignated preferred name (PT)
729Superparamagnetic iron oxideFull form of descriptor (FN)
730Neomycin sulfatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
731aluminum hydroxide 80 MG / magnesium trisilicate 14.2 MG Chewable TabletSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
732Amphotericin BFull form of descriptor (FN)
733AminobenzylpenicillinDesignated preferred name (PT)
734O-desmethylvenlafaxineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
735Lysine racemaseDesignated preferred name (PT)
736Depolarizing agentFull form of descriptor (FN)
737paricalcitolFull form of descriptor (FN)
738Amrinone-containing productIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
739AmsacrineFull form of descriptor (FN)
740NiclosamideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
741TreandaBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
742Amyl nitriteIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
743AmylaseFull form of descriptor (FN)
744NitrazepamDesignated preferred name (PT)
745pantethine 300 MG Oral CapsuleSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
746Amyloid PSynonym (SY)Synonym of another TTY, given for clarity.
747PulmozymeBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
748AA proteinDesignated preferred name (PT)
749NAD^+^ pyrophosphorylaseFull form of descriptor (FN)
750nomifensineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
751lamoTRIgine 25 MG Oral Tablet 35 Count PackSynonym (SY)Synonym of another TTY, given for clarity.
752AmyloseDesignated preferred name (PT)
753PeranexBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
754AnabasineFull form of descriptor (FN)
755NubainBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
756AnafranilBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
757Central nervous system stimulantSynonym (SY)Synonym of another TTY, given for clarity.
758bismuth subsalicylate 262 MG Chewable Tablet (112) / metroNIDAZOLE 250 MG Oral Tablet (56) / tetracycline HCl 500 MG Oral Capsule (56) PackPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
759prussian blue insoluble 500 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
760AnalgesicDesignated preferred name (PT)
761OchratoxinDesignated preferred name (PT)
762Kariva 28 Day PackBrand Name Pack (BPCK){# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name]
763insulin human, rDNA origin Dry Powder InhalerSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
764Arginine carboxypeptidaseDesignated preferred name (PT)
765OncoproteinFull form of descriptor (FN)
766AnaphylatoxinFull form of descriptor (FN)
767Ophthalmic SolutionDose Form (DF)
768SynflexBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
769AnaspazBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
770OrnidazoleDesignated preferred name (PT)
771AGP - alpha-1 acid glycoproteinSynonym (SY)Synonym of another TTY, given for clarity.
772Agkistrodon serine proteinaseDesignated preferred name (PT)
773Nonessential amino acidFull form of descriptor (FN)
774OsteonectinDesignated preferred name (PT)
775Substance with antiandrogen mechanism of actionSynonym (SY)Synonym of another TTY, given for clarity.
776G-strophanthinSynonym (SY)Synonym of another TTY, given for clarity.
777AndrogenFull form of descriptor (FN)
778OxazepamDesignated preferred name (PT)
779ReductaseDesignated preferred name (PT)
780AndrostaneDesignated preferred name (PT)
781HbO2 - OxyhemoglobinDesignated preferred name (PT)
782OxipurinolDesignated preferred name (PT)
783saralasin acetatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
784ADIONE - delta 4-androstenedioneFull form of descriptor (FN)
785PAI-1Synonym (SY)Synonym of another TTY, given for clarity.
786Water soluble vitaminSynonym (SY)Synonym of another TTY, given for clarity.
787tapentadolFull form of descriptor (FN)
788PancreatinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
789SulfacitineDesignated preferred name (PT)
790miconazole Topical Powder [Micatin]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
791ParamethasoneDesignated preferred name (PT)
792ergonovine 0.2 MG [Ergotrate]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
793PargylineDesignated preferred name (PT)
794ParvalbuminFull form of descriptor (FN)
795Compound 347Brand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
796PefloxacinFull form of descriptor (FN)
797thrombin Topical Solution [Thrombogen]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
798Benzylpenicillin-containing productFull form of descriptor (FN)
799CotabfluBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
800Dianeal PD-2/4.25Brand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
801Sodium stibogluconateDesignated preferred name (PT)
802Pepsinogen 2Synonym (SY)Synonym of another TTY, given for clarity.
803chromic chloride 20.5 MCG (chromium 4 MCG) / copper sulfate 1.57 MG (copper 0.4 MG) / manganese sulfate 0.308 MG (manganese 0.1 MG) / zinc sulfate 4.39 MG (zinc 1 MG) per ML Injectable SolutionSynonym (SY)Synonym of another TTY, given for clarity.
804peptonesIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
805PerhexilineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
806Motrin 100 MG Oral TabletPrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
807menthol 6.5 MG [Halls]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
808pertussis vaccineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
809carbidopa 10 MG / levodopa 100 MG [Parcopa]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
810lacosamide 50 MG Oral TabletFull form of descriptor (FN)
811phenacetinIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
812PhenazopyridineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
813PhenindioneDesignated preferred name (PT)
814betamethasone / terfenadineMultiple Ingredients (MIN)Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD.
815PhenprocoumonIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
816PhenylbutazoneDesignated preferred name (PT)
817AnestheticDesignated preferred name (PT)
818guaifenesin / pyrilamineTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
819Local anestheticFull form of descriptor (FN)
820Anethole trithioneDesignated preferred name (PT)
821Phosphatidate phosphataseFull form of descriptor (FN)
822carisoprodol / dexamethasone / tenoxicamMultiple Ingredients (MIN)Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD.
823Phosphopyruvate carboxylase (GTP)Designated preferred name (PT)
824Lecithinase ASynonym (SY)Synonym of another TTY, given for clarity.
825Phosphonacetic acidFull form of descriptor (FN)
826Zn(2+) G peptidaseFull form of descriptor (FN)
827Phosphorylase phosphataseFull form of descriptor (FN)
828Fosphenytoin sodiumDesignated preferred name (PT)
829methenamine mandelate 500 MG / sodium phosphate, monobasic 500 MG [Utac]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
830bicalutamideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
831Angiotensin 1Full form of descriptor (FN)
832NexteroneBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
833desmopressin acetate 0.2 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
834Angiotensin 3Full form of descriptor (FN)
835PipradrolDesignated preferred name (PT)
836Substance with angiotensin-converting enzyme inhibitor mechanism of actionSynonym (SY)Synonym of another TTY, given for clarity.
837AngiotonaseDesignated preferred name (PT)
838AngiotensinogenDesignated preferred name (PT)
839AngiotensinDesignated preferred name (PT)
840Plasma proteinDesignated preferred name (PT)
841T-PAFull form of descriptor (FN)
842Platelet activating factorDesignated preferred name (PT)
843Platelet factor 4Full form of descriptor (FN)
844MinirinBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
845carbamazepine 200 MG Extended Release Oral Capsule [Equetro]Semantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name
846benzoyl peroxide 5.25 % Medicated Liquid SoapSynonym (SY)Synonym of another TTY, given for clarity.
847vitamin K Oral CapsuleSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
848Humibid L.A. Reformulated Apr 2009Brand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
849redtop grass pollen extract 100000 UNT/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
850amantadine hydrochloride 100 MG [Mantadine]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
851Anion exchange resinDesignated preferred name (PT)
852Pectin depolymeraseDesignated preferred name (PT)
853quinidine gluconate 330 MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
854Polynucleotide phosphorylaseFull form of descriptor (FN)
855benzocaine 15 MG / menthol 4 MG Oral LozengePrescribable Name (PSN)Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.
856Polyoxethylene sorbitan oleateSynonym (SY)Synonym of another TTY, given for clarity.
857PVA - Polyvinyl alcoholDesignated preferred name (PT)
858PorphyrinFull form of descriptor (FN)
859guaiacolsulfonate 60 MG/ML / hydrocodone bitartrate 1 MG/ML [Hydone Formula Liquid]Semantic Branded Drug Component (SBDC)Ingredient + Strength + Brand Name
860guaifenesin 60 MG/ML / hydrocodone bitartrate 0.7 MG/ML [Codiclear DH]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
861AnserineDesignated preferred name (PT)
862Ant venomFull form of descriptor (FN)
863AntacidFull form of descriptor (FN)
864PrednisoneTall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
865AntazolineDesignated preferred name (PT)
866antazoline phosphatePrecise Ingredient (PIN)A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms.
867Acacia pollen extract 1000 UNT/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
868Substance with anthelmintic mechanism of actionSynonym (SY)Synonym of another TTY, given for clarity.
869AnthocyaninDesignated preferred name (PT)
870ProcainamideIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
871Uridine diphosphate-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligaseSynonym (SY)Synonym of another TTY, given for clarity.
872ProflavineIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
873DithranolSynonym (SY)Synonym of another TTY, given for clarity.
874ProlixinBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
875Phosphoribosyl-anthranilate pyrophosphorylaseDesignated preferred name (PT)
876Anthranilate synthaseDesignated preferred name (PT)
877propiomazineDesignated preferred name (PT)
878PropofolIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
879Product containing propylamine (product)Designated preferred name (PT)
880Prostaglandin G/H synthaseSynonym (SY)Synonym of another TTY, given for clarity.
881Product containing F series prostaglandin (product)Designated preferred name (PT)
882Antirheumatic agentDesignated preferred name (PT)
883Antiarrhythmic agentDesignated preferred name (PT)
884Anti-infectivesSynonym (SY)Synonym of another TTY, given for clarity.
885Antiseptic agentDesignated preferred name (PT)
886ProteoglycanFull form of descriptor (FN)
887Antiinflammatory agentDesignated preferred name (PT)
888ProtoporphyrinFull form of descriptor (FN)
889Nonsteroidal anti-inflammatory agentSynonym (SY)Synonym of another TTY, given for clarity.
890aripiprazoleIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
891Calcium Chloride 0.000996 MEQ/ML / Glucose 1.4 MG/ML / Magnesium Chloride 0.0000245 MEQ/ML / NaCl 0.00368 MEQ/ML / Sodium Lactate 0.0016 MEQ/ML Intraperitoneal SolutionSemantic Clinical Drug (SCD)Ingredient + Strength + Dose Form
892butafosfan 100 MG/MLSemantic Clinical Drug Component (SCDC)Ingredient + Strength
893Gamma-glu-X carboxypeptidaseDesignated preferred name (PT)
894Pulmonary surfactantDesignated preferred name (PT)
895Product containing purine nucleoside (product)Designated preferred name (PT)
896AntibioticFull form of descriptor (FN)
897Substance with aminoglycoside structure and antibacterial mechanism of actionFull form of descriptor (FN)
898AnthracyclineDesignated preferred name (PT)
899sodium bitartrateIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
900Antineoplastic antibioticDesignated preferred name (PT)
901PyrimethamineFull form of descriptor (FN)
902pyritinolDesignated preferred name (PT)
903TL-Hist CDBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
904AntibodyFull form of descriptor (FN)
905Bifidobacterium Infantis 2000000 UNT/MGSemantic Clinical Drug Component (SCDC)Ingredient + Strength
906ANASynonym (SY)Synonym of another TTY, given for clarity.
907Bacterial antibodyDesignated preferred name (PT)
908Antibody to fungusFull form of descriptor (FN)
909Helminth antibodyFull form of descriptor (FN)
910Heterophile antibodyDesignated preferred name (PT)
911Monoclonal immunoglobulinDesignated preferred name (PT)
912Replacement preparationDesignated preferred name (PT)
913DiflorasoneFull form of descriptor (FN)
914Viral antibodyFull form of descriptor (FN)
915Rattlesnake venomDesignated preferred name (PT)
916Adrenergic receptorFull form of descriptor (FN)
917Complement receptorFull form of descriptor (FN)
918methyltestosterone 10 MG Oral Tablet [Android-10]Synonym (SY)Synonym of another TTY, given for clarity.
919Histamine H1 receptorDesignated preferred name (PT)
920Muscarinic receptorDesignated preferred name (PT)
921Steroid receptorDesignated preferred name (PT)
922Collyrium FreshBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
923AnticoagulantFull form of descriptor (FN)
924HYDROmorphone Rectal Suppository [Dilaudid]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
925DrisdolBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
926AnticonvulsantDesignated preferred name (PT)
927AntidepressantFull form of descriptor (FN)
928Tricyclic antidepressantFull form of descriptor (FN)
929Antidiarrheal agentFull form of descriptor (FN)
930AntidoteFull form of descriptor (FN)
931Antiemetic agentDesignated preferred name (PT)
932Mag-Ox 400Brand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
933glyBURIDE Oral Tablet [Micronase]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
934Naphcon forteBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
935NolahistBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
936OphthocortBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
937Pediaflor DropsBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
938citric acid / potassium citrate Oral Solution [Polycitra-K]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
939medroxyPROGESTERone Oral Tablet [Provera]Tall Man Lettering Synonym (TMSY)Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.
940CIC - Circulating immune complexFull form of descriptor (FN)
941Slo-bid GyrocapsBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
942Sus-Phrine InjectionBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
943Antigenic determinantDesignated preferred name (PT)
944perphenazine Injectable Solution [Trilafon]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
945methoxamine Injectable Solution [Vasoxyl]Semantic Branded Drug Form (SBDF)Ingredient + Dose Form + Brand Name
946AntigenFull form of descriptor (FN)
947Antigen of bacteriaSynonym (SY)Synonym of another TTY, given for clarity.
948Cluster of differentiation antigenSynonym (SY)Synonym of another TTY, given for clarity.
949Leukocyte 3aSynonym (SY)Synonym of another TTY, given for clarity.
950Rutoside-containing productFull form of descriptor (FN)
951chloramphenicol Ophthalmic OintmentSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
952SalicylanilideDesignated preferred name (PT)
953Artificial saliva agentDesignated preferred name (PT)
954Antigen of FungusFull form of descriptor (FN)
955Helminth antigenFull form of descriptor (FN)
956Heterophil antigenFull form of descriptor (FN)
957ichthammol 20 % Topical OintmentSynonym (SY)Synonym of another TTY, given for clarity.
959Fibrous proteinDesignated preferred name (PT)
960Hyoscine-containing productIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
961Antigen of ProtozoaFull form of descriptor (FN)
962QuinalbarbitoneFull form of descriptor (FN)
963Thymus-independent antigenDesignated preferred name (PT)
964seleniteIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
965Antigen of virusDesignated preferred name (PT)
966levothyroxine sodium 0.025 MG Oral Tablet [Eltroxin]Semantic Branded Drug (SBD)Ingredient + Strength + Dose Form + Brand Name
967SerentilBrand Name (BN)A proprietary name for a family of products containing a specific active ingredient.
968Antihypertensive agentFull form of descriptor (FN)
969miconazole Buccal TabletSemantic Clinical Drug Form (SCDF)Ingredient + Dose Form
970Buccal TabletDose Form (DF)
971Anti lymphocyte antibodyDesignated preferred name (PT)
972Anas platyrhynchos allergenic extractIngredient (IN)A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN).
973Antilymphocyte immunoglobulinDesignated preferred name (PT)
974Product containing Salmonella typhimurium antiserum (medicinal product)Designated preferred name (PT)
975Substance with antimalarial mechanism of actionFull form of descriptor (FN)
976AntimetaboliteFull form of descriptor (FN)
977N-methyl-L-amino-acid oxidaseFull form of descriptor (FN)
978Substance with mitotic inhibitor mechanism of actionDesignated preferred name (PT)
979Prephytoene-diphosphate synthaseFull form of descriptor (FN)
980SincalideDesignated preferred name (PT)
981Antimony potassium tartrateDesignated preferred name (PT)
982Nucleoside phosphoacylhydrolaseFull form of descriptor (FN)
983Antimony sodium tartrateFull form of descriptor (FN)
984Substance with muscarinic receptor antagonist mechanism of actionSynonym (SY)Synonym of another TTY, given for clarity.
985Complement component, precursorDesignated preferred name (PT)
986Cephalothin sodiumBritish preferred term (PTGB)
987Blood group antigen HofDesignated preferred name (PT)
988Antineoplastic agentFull form of descriptor (FN)
989Blood group antibody BocDesignated preferred name (PT)
990Benzylpenicillin sodiumFull form of descriptor (FN)
991Sodium taurocholateDesignated preferred name (PT)
992Blood group antigen Sp>1<Full form of descriptor (FN)
993Blood group antibody Pr>a<Designated preferred name (PT)
994Blood group antigen HaaseFull form of descriptor (FN)
995Antiparkinsonian agentFull form of descriptor (FN)
996Alpha-2-antiplasminFull form of descriptor (FN)
997Blood group antibody CrossDesignated preferred name (PT)
998Substance with antiprotozoal mechanism of actionDesignated preferred name (PT)
999SpiperoneFull form of descriptor (FN)